J W C Alffenaar Selected Research

Kanamycin

1/2018	In Vitro Susceptibility of Mycobacterium tuberculosis to Amikacin, Kanamycin, and Capreomycin.
1/2017	Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant Tuberculosis.
1/2016	Immunoassay Analysis of Kanamycin in Serum Using the Tobramycin Kit.
9/2015	Limited sampling strategies for therapeutic drug monitoring of amikacin and kanamycin in patients with multidrug-resistant tuberculosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J W C Alffenaar Research Topics

Disease

11	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2019 - 01/2011
10	Tuberculosis (Tuberculoses) 02/2019 - 08/2008
4	Critical Illness (Critically Ill) 12/2022 - 12/2017
4	Invasive Candidiasis 12/2022 - 08/2012
4	Infections 01/2018 - 01/2010
2	Body Weight (Weight, Body) 12/2017 - 09/2010
2	Extensively Drug-Resistant Tuberculosis 01/2017 - 03/2011
2	Aspergillosis 08/2012 - 06/2010
2	Meningeal Tuberculosis (Tuberculous Meningitis) 10/2009 - 06/2008
1	Sepsis (Septicemia) 12/2022
1	Hearing Loss (Hearing Impairment) 01/2017
1	Drug-Related Side Effects and Adverse Reactions 01/2016
1	Inflammation (Inflammations) 01/2016
1	Liver Diseases (Liver Disease) 01/2016
1	Hypersensitivity (Allergy) 10/2011
1	Buruli Ulcer 09/2010
1	Seizures (Absence Seizure) 07/2007
1	Pyridoxine-dependent epilepsy 07/2007

Drug/Important Bio-Agent (IBA)

6	Moxifloxacin (Avelox)FDA Link 09/2014 - 06/2008
5	Rifampin (Rifampicin)FDA LinkGeneric 01/2019 - 09/2010
4	Kanamycin FDA Link 01/2018 - 09/2015
3	Amikacin (A.M.K)FDA LinkGeneric 01/2018 - 09/2015
3	Clarithromycin (Biaxin)FDA LinkGeneric 04/2014 - 09/2010
2	Micafungin (FK463)FDA Link 12/2022 - 12/2017
2	Fluconazole (Zonal)FDA LinkGeneric 01/2021 - 01/2021
2	FluoroquinolonesIBA 02/2019 - 01/2011
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2019 - 01/2018
2	Ertapenem (Invanz)FDA Link 01/2018 - 01/2017
2	AminoglycosidesIBA 01/2017 - 01/2016
2	Voriconazole (Vfend)FDA LinkGeneric 01/2016 - 06/2010
2	Linezolid (Zyvox)FDA Link 08/2013 - 11/2012
1	Rifabutin (Ansamycin)FDA Link 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2018
1	Capreomycin (Capastat)FDA Link 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	bedaquiline (R207910)IBA 08/2016
1	Cytochrome P-450 CYP2C19IBA 01/2016
1	C-Reactive ProteinIBA 01/2016
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2016
1	Sulfamethoxazole FDA LinkGeneric 01/2016
1	Anti-Infective Agents (Microbicides)IBA 11/2012
1	EnzymesIBA 08/2012
1	Caspofungin (Cancidas)FDA Link 08/2012
1	PNU-100480IBA 03/2011
1	Ofloxacin (Ofloxacine)FDA LinkGeneric 01/2011
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2011
1	Gatifloxacin (Zymar)FDA Link 01/2011
1	Levofloxacin (Levaquin)FDA Link 01/2011
1	Streptomycin (Streptomycin Sulfate)FDA Link 09/2010
1	Antifungal AgentsIBA 01/2010
1	AzolesIBA 01/2010
1	Ethambutol (Myambutol)FDA LinkGeneric 08/2008
1	Pyridoxine (Pyridoxin)FDA LinkGeneric 07/2007

Therapy/Procedure

5	Therapeutics 12/2022 - 07/2007
2	Duration of Therapy 01/2017 - 01/2016
1	Liver Transplantation 08/2012
1	Intramuscular Injections 09/2010
1	Intravenous Administration 06/2010
1	Oral Administration 06/2010